If you’ve been researching treatments for type 2 diabetes or weight management, you’ve probably heard about Mounjaro (tirzepatide) and Ozempic (semaglutide). Both are weekly injectable medications that help lower blood sugar and support weight loss — but they’re not exactly the same.
Here’s a breakdown on how they compare:
| Feature | Mounjaro (Tirzepatide) | Ozempic (Semaglutide) |
|---|---|---|
| Type | Dual GIP + GLP-1 receptor agonist | GLP-1 receptor agonist |
| FDA Approval | Type 2 diabetes (also as Zepbound for obesity) | Type 2 diabetes (also as Wegovy for obesity) |
| Blood Sugar Reduction | Up to ~2% HbA1c drop | Up to ~1.5% HbA1c drop |
| Average Weight Loss | 15–20% body weight | 10–15% body weight |
| Dosing | Weekly, 2.5–15 mg | Weekly, 0.25–2 mg |
The key difference: Mounjaro targets two hormones (GIP + GLP-1), while Ozempic targets only GLP-1.
Both medications have similar side effects, especially when first starting:
Nausea
Vomitting
Diarrhea
Decreased appetite
Most side effects improve as the body adjusts, especially when doses are increased gradually.
Learn how GLP-1 help with chronic condition reversal:
Take this quick quiz to see if you may benefit from a GLP-1–based therapy and receive personalized results instantly.
Complete the 2-minute quiz to win Free Doctor Teleconsult & RM150 Voucher!
Please select at least one option.
Please select at least one option.
Please describe your health ambition.
Please select at least one option.
Motivation Level: 5/10
📩 You’ll receive your full result & RM150 voucher via WhatsApp & Email.
My HbA1c dropped from 8.2% to 5.9% after 5 months on GLP-1 and doctor follow-ups. I finally feel free from sugar controlling me.
GLP-1 curbed my cravings — I lost 11 kg in 3 months. I’ve regained focus, health, and confidenct and in control now.
Mounjaro is part of a newer class of medications designed to support both blood sugar management and weight loss.
Research shows that Mounjaro can lower blood sugar and promote greater weight reduction compared to some existing treatments.
A single injection per week makes it easier for patients to follow their treatment plan consistently.
Mounjaro works by activating both GLP-1 and GIP receptors, providing a more comprehensive effect on appetite control and glucose regulation.
Consult with our doctors online – safe, fast, and confidential.
✔️ Get expert advice from certified doctors
✔️ 100% confidential and secure consultation
✔️ No need to travel or wait in queues
✔️ Receive prescriptions and treatments at home
Answer:
GLP-1 medications improve blood sugar control, reduce appetite, and promote fat loss — which in turn lowers the risk of diabetes, hypertension, and heart disease.
Answer:
Studies show 15–20% average weight loss and improvements in blood sugar, cholesterol, and blood pressure within just 3–6 months.
Answer:
Some users experience nausea, vomiting, or mild digestive discomfort — usually temporary and reduced when doses are increased gradually.
Answer:
It’s generally safe under doctor supervision. Patients with thyroid conditions or pancreatitis should discuss alternative options with their healthcare provider.
Answer:
Some patients successfully reduce or stop diabetes or blood pressure medications after significant improvement — always under medical review.
Amira, 28